Enhanced angiogenesis promoted by human umbilical mesenchymal stem cell transplantation in stroked mouse is Notch1 signaling associated

Neuroscience

Volumn 290, Issue , 2015, Pages 288-299

  Zhu, J ^a   Liu, Q ^a   Jiang, Y ^a   Wu, L ^a   Xu, G ^a   Liu, X ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Angiogenesis; Hes1; Human umbilical mesenchymal stem cells; Notch1 signaling; Stroke; VEGF A

Indexed keywords

GAMMA SECRETASE INHIBITOR; MESSENGER RNA; N [N (3,5 DIFLUOROPHENACETYL)ALANYL]PHENYLGLYCINE TERT BUTYL ESTER; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; GLUCOSE; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; NOTCH1 PROTEIN, HUMAN; NOTCH1 PROTEIN, MOUSE; SECRETASE; VEGFA PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR INTERACTION; MOUSE; NERVE CELL CULTURE; NONHUMAN; PROTEIN DOMAIN; PROTEIN SECRETION; UMBILICAL MESENCHYMAL STEM CELL TRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL HYPOXIA; CORD BLOOD STEM CELL TRANSPLANTATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; FETUS BLOOD; MESENCHYMAL STROMA CELL; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SECRETION (PROCESS); SIGNAL TRANSDUCTION; STROKE;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL BLOOD; GLUCOSE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NEURONS; RANDOM ALLOCATION; RECEPTOR, NOTCH1; RNA, MESSENGER; SIGNAL TRANSDUCTION; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923112371     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.01.038     Document Type: Article

References (34)

1. Beck H., Plate K.H. Angiogenesis after cerebral ischemia. Acta Neuropathol 2009, 117:481-496.
2. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
3. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003, 92:692-699.
4. Chung D.J., Choi C.B., Lee S.H., Kang E.H., Lee J.H., Hwang S.H., Han H., Lee J.H., Choe B.Y., Lee S.Y., Kim H.Y. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res 2009, 87:3554-3567.
5. D'Souza B., Meloty-Kapella L., Weinmaster G. Canonical and non-canonical Notch ligands. Curr Top Dev Biol 2010, 92:73-129.
6. Dufraine J., Funahashi Y., Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008, 27:5132-5137.
7. Edwards S.S., Zavala G., Prieto C.P., Elliott M., Martinez S., Egana J.T., Bono M.R., Palma V. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration. Angiogenesis 2014.
8. Ergul A., Alhusban A., Fagan S.C. Angiogenesis: a harmonized target for recovery after stroke. Stroke 2012, 43:2270-2274.
9. Gonzalez M.E., Moore H.M., Li X., Toy K.A., Huang W., Sabel M.S., Kidwell K.M., Kleer C.G. EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc Natl Acad Sci U S A 2014, 111:3098-3103.
10. Greenblatt D.Y., Cayo M.A., Adler J.T., Ning L., Haymart M.R., Kunnimalaiyaan M., Chen H. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells. Ann Surg 2008, 247:1036-1040.
11. Gupta R., Hong D., Iborra F., Sarno S., Enver T. NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 2007, 316:590-593.
12. Hao L., Zou Z., Tian H., Zhang Y., Zhou H., Liu L. Stem cell-based therapies for ischemic stroke. BioMed Res Int 2014, 2014:468748.
13. Henderson R.D., Eliasziw M., Fox A.J., Rothwell P.M., Barnett H.J. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke 2000, 31:128-132.
14. Iso T., Kedes L., Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003, 194:237-255.
15. Koh S.H., Kim K.S., Choi M.R., Jung K.H., Park K.S., Chai Y.G., Roh W., Hwang S.J., Ko H.J., Huh Y.M., Kim H.T., Kim S.H. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008, 1229:233-248.
16. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
17. Kuhnert F., Kirshner J.R., Thurston G. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc Cell 2011, 3:20.
18. Lawson N.D., Vogel A.M., Weinstein B.M. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 2002, 3:127-136.
19. Lee J.H., Suk J., Park J., Kim S.B., Kwak S.S., Kim J.W., Lee C.H., Byun B., Ahn J.K., Joe C.O. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway. Mol Cancer Res 2009, 7:1663-1671.
20. Li Y., Hiroi Y., Ngoy S., Okamoto R., Noma K., Wang C.Y., Wang H.W., Zhou Q., Radtke F., Liao R., Liao J.K. Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation 2011, 123:866-876.
21. Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009, 21:154-165.
22. Ma J., Sawai H., Ochi N., Matsuo Y., Xu D., Yasuda A., Takahashi H., Wakasugi T., Takeyama H. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem 2009, 331:161-171.
23. Misra V., Ritchie M.M., Stone L.L., Low W.C., Janardhan V. Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology 2012, 79:S207-S212.
24. Ranganath S.H., Levy O., Inamdar M.S., Karp J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012, 10:244-258.
25. Sahara M., Hansson E.M., Wernet O., Lui K.O., Spater D., Chien K.R. Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells. Cell Res 2014.
26. Szpak G.M., Lechowicz W., Lewandowska E., Bertrand E., Wierzba-Bobrowicz T., Dymecki J. Border zone neovascularization in cerebral ischemic infarct. Folia Neuropathol 1999, 37:264-268.
27. Vu Q., Xie K., Eckert M., Zhao W., Cramer S.C. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology 2014, 82:1277-1286.
28. Wong G.W., Knowles G.C., Mak T.W., Ferrando A.A., Zuniga-Pflucker J.C. HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRbeta-selected mouse thymocytes. Blood 2012, 120:1439-1448.
29. Xiong Y., Mahmood A., Chopp M. Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs 2010, 11:298-308.
30. Yancopoulos G.D., Klagsbrun M., Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 1998, 93:661-664.
31. Zhang L., Li Y., Zhang C., Chopp M., Gosiewska A., Hong K. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011, 42:1437-1444.
32. Zhang Z.G., Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009, 8:491-500.
33. Zhong Q., Zhou Y., Ye W., Cai T., Zhang X., Deng D.Y. Hypoxia-inducible factor 1-alpha-AA-modified bone marrow stem cells protect PC12 cells from hypoxia-induced apoptosis, partially through VEGF/PI3K/Akt/FoxO1 pathway. Stem Cells Dev 2012, 21:2703-2717.
34. Zhu J., Jiang Y., Wu L., Lu T., Xu G., Liu X. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience 2012, 202:342-351.